Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dentsply Sirona (XRAY) EBITDA Margin (2016 - 2025)

Dentsply Sirona's EBITDA Margin history spans 17 years, with the latest figure at 14.46% for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin rose 4178.0% year-over-year to 14.46%, compared with a TTM value of 11.47% through Dec 2025, up 1171.0%, and an annual FY2025 reading of 11.47%, up 1171.0% over the prior year.
  • EBITDA Margin for Q4 2025 was 14.46% at Dentsply Sirona, up from 24.12% in the prior quarter.
  • The five-year high for EBITDA Margin was 15.59% in Q4 2021, with the low at 128.62% in Q3 2022.
  • Average EBITDA Margin over 5 years is 9.68%, with a median of 5.85% recorded in 2022.
  • Year-over-year, EBITDA Margin plummeted -14131bps in 2022 and then surged 10370bps in 2023.
  • Tracing XRAY's EBITDA Margin over 5 years: stood at 15.59% in 2021, then tumbled by -58bps to 6.61% in 2022, then rose by 9bps to 7.21% in 2023, then tumbled by -880bps to 56.24% in 2024, then soared by 74bps to 14.46% in 2025.
  • Per Business Quant, the three most recent readings for XRAY's EBITDA Margin are 14.46% (Q4 2025), 24.12% (Q3 2025), and 13.68% (Q2 2025).